BOSTON--(BUSINESS WIRE)--CYBRIC, provider of the first continuous application security platform, today announced that Cytobank, a cloud-based software solution that accelerates biomedical research productivity using machine learning tools, has deployed CYBRIC to secure its platform to protect sensitive biomedical research data. CYBRIC helps Cytobank ensure alignment with necessary, but often complex, regulatory and compliance standards required by its leading pharmaceutical customers. By enabling Cytobank to automate and schedule scans at the code and server level, CYBRIC reduces security risk while also freeing up the company’s engineering and DevOps teams to focus on more strategic technology initiatives.
“Cytobank customers rely on our sophisticated machine learning algorithms to enhance research productivity by accelerating the analysis of complex data,” said Angela Landrigan, director of products and security officer of Cytobank. “It’s critical that we maintain robust security to protect our large database of sensitive biomedical data while also staying up to date with the ever-evolving information security guidelines. With continuous, automated scanning, CYBRIC provides unmatched visibility into our application’s security posture, identifying and eliminating security gaps, while enabling us to stay compliant and meet individual customer requirements.”
CYBRIC’s platform is the first to automate and orchestrate code and application security across the development lifecycle, reducing application vulnerability exposure without impacting the production environment. Prior to CYBRIC, Cytobank used a manual approach. The ability to automate and schedule scans using CYBRIC’s platform enables Cytobank’s continuous visibility and assurance across the application testing landscape. CYBRIC also empowers Cytobank with a centralized and integrated dashboard, delivering a holistic view of the company’s security posture at all times.
“Cytobank and security conscious organizations across the globe are moving to more innovative security solutions as they aim to defend themselves against cyberattacks, which are increasing in both frequency and sophistication,” said Ernesto DiGiambattista, CEO and founder of CYBRIC. “CYBRIC’s ability to automate the security testing process while integrating with Cytobank’s existing security tools delivers peace of mind when protecting sensitive healthcare information and ensures confidence that all security and compliance standards are met.”
To learn more about how Cytobank uses the CYBRIC platform to provide continuous visibility into its security posture, visit the CYBRIC website.
CYBRIC is the first to orchestrate and automate code and application security across the development lifecycle. The CYBRIC continuous application security platform integrates security into the development process and delivers frictionless security assurance from code commit to application delivery. To learn more visit www.cybric.io or follow us on Twitter @cybric.
Cytobank Inc. is the leading cloud-based analysis platform utilizing machine learning algorithms for collaborative biomedical research. Prominent pharmaceutical, biotechnology, and academic researchers around the world use our solution to develop deep understandings of the immune system at the single cell level. For more information, please visit https://www.cytobank.org/.